QOF Plus Year 1 - Imperial College London

Appendix 1 – Background to the QOF+ development process ..................................................... 100Composition of the QOF+ development group ............................................................................... 100Process employed by the QOF+ development group ...................................................................... 100Approach to development of the scheme ....................................................................................... 100Appendix 2 – Methodology for the extension of existing clinical QOF targets .............................. 102Selection of candidate existing indicators for revised upper thresholds ......................................... 102Methodology for revised target setting for existing clinical indicators ........................................... 103Methodology for point allocation for existing clinical indicators .................................................... 106Minimum attainment thresholds .................................................................................................... 109Exception reporting ......................................................................................................................... 110List turnover ..................................................................................................................................... 115References ....................................................................................................................................... 115Appendix 3 – Current levels of attainment and exception reporting for existing clinical indicators 116Purpose of these data ...................................................................................................................... 116Data sources .................................................................................................................................... 116Using the graphs .............................................................................................................................. 117Asthma 6 .......................................................................................................................................... 118BP 5 .................................................................................................................................................. 119CHD 6 ............................................................................................................................................... 120CHD 8 ............................................................................................................................................... 121CHD 10 ............................................................................................................................................. 122CS 1 .................................................................................................................................................. 123DM 12 .............................................................................................................................................. 124DM 17 .............................................................................................................................................. 125DM 20 .............................................................................................................................................. 126MH 6 ................................................................................................................................................ 127Stroke 6 ............................................................................................................................................ 128Stroke 8 ............................................................................................................................................ 129Appendix 4 – Methodology for the design and development of the new indicators for QOF+ ...... 130Methodology for the creation of new indicator areas long list ....................................................... 130Consultation with local stakeholders to select priority areas for the development of QOF+indicators ......................................................................................................................................... 132Methodology for the development of new indicators .................................................................... 134Consultation with local practices ..................................................................................................... 135Assessment of new indicators ......................................................................................................... 135Response to feedback on proposed new indicators ........................................................................ 136Final consultation with local practices ............................................................................................. 137Methodology for point allocation for the new QOF+ indicators ..................................................... 137Communication with the PCT’s health informatics team ................................................................ 138Appendix 5 – Methodology for the development of the training and support package ................. 140Development of the training and support package ......................................................................... 140Results of data analysis of practice achievement for selected existing QOF indicators .................. 141Results of practice training and support needs assessment ........................................................... 141Appendix 6 – Summary of the QOF+ scheme ............................................................................. 142